Tommy John, MLB pitcher whose elbow surgery revolutionized baseball, dies at 83

An injury that should have ended his career at 31 became a doorway for thousands
Tommy John's willingness to undergo experimental surgery transformed how sports medicine treats career-threatening injuries.
Mark

What made this injury different from others pitchers had suffered before?

Mimi

The ulnar collateral ligament is small but essential—it's what holds your elbow together when you're throwing a baseball at high velocity. Before 1974, if you tore it, there was no way to fix it. You were done.

Mark

And no one had ever tried to repair it surgically?

Mimi

Not successfully. Jobe's idea was radical: take a healthy tendon from elsewhere in the arm and use it to replace what was torn. It had never been done before. John was the first person willing to try it.

Mark

Did he know he might never pitch again?

Mimi

He had to have known. He was 31, at the peak of his career. The surgery could have ended everything. But the alternative was certain retirement anyway.

Mark

How did it change baseball?

Mimi

It didn't just change baseball. It changed all of sports. Once it worked for John, surgeons started performing it on other athletes. Now it's routine. Young pitchers get the surgery and come back stronger than before.

Mark

Stronger? How is that possible?

Mimi

The grafted tendon is often stronger than the original ligament. Some athletes return to play at higher levels than they reached before the injury. It's become almost expected in professional baseball.

  • A small band of tissue in John's pitching elbow tore in 1974, and with it, what should have been the irreversible end of a professional career.
  • Surgeon Frank Jobe proposed something that had never been done — grafting a tendon to reconstruct the damaged ligament — and John agreed to be the unknown experiment.
  • Against all expectation, John returned to pitch fourteen more seasons, winning 164 additional games and reaching the World Series, proof that the impossible had become real.
  • The procedure spread through sports medicine like a quiet revolution, eventually becoming so routine that young pitchers began to treat it as an expected chapter in a long career rather than a catastrophe.
  • John's death at 83 closes the life of the man, but the surgery bearing his name continues to restore careers daily, making him one of the rare athletes whose greatest contribution was never a game-winning pitch.

Tommy John, the Major League Baseball pitcher who in 1974 became the first to undergo ulnar collateral ligament reconstruction, died at 83, leaving behind a legacy that transcends statistics. At a moment when a torn ligament meant the end of a career, John chose the uncertain path of experimental surgery, and in doing so, transformed not only his own fate but the possibilities available to generations of athletes. His name became a medical term — a rare honor that speaks to how profoundly one person's willingness to be first can reshape an entire field of human endeavor.

Tommy John was 31 years old when he tore the ulnar collateral ligament in his pitching elbow — an injury that, in 1974, meant a career was finished. No pitcher had ever come back from it. The expectation was simple: you went home.

John did not go home. He agreed to undergo an experimental procedure with surgeon Frank Jobe in Los Angeles — a tendon graft that would reconstruct the damaged ligament from tissue taken elsewhere in his own forearm. No one knew if it would work. No one knew if he would ever throw a baseball again at any level, let alone the major leagues.

He did. John returned to pitch for fourteen more seasons, won 164 additional games, earned four All-Star selections, and won a World Series. But the numbers were never really the point. The point was the door he had opened by agreeing to be first.

The procedure became known as Tommy John surgery, and it quietly rewrote what was possible in sports medicine. A diagnosis that had once meant retirement became a diagnosis that meant rehabilitation. Pitchers, quarterbacks, tennis players, and gymnasts who faced the same torn ligament found a path back to competition because one man had been willing to be the guinea pig.

Surgeons refined the technique over the decades. The surgery grew so common in baseball that some organizations began to treat it as an almost inevitable milestone for young pitchers. John died at 83, having lived a long and full life after an injury that should have ended everything at 31 — and having given countless others the same chance.

Tommy John was 31 years old when his left arm betrayed him. It was 1974, and the left-handed pitcher felt something tear deep in his pitching elbow—the ulnar collateral ligament, a small but critical band of tissue that had never been successfully repaired before. For any pitcher in that era, such an injury meant the end. The career was over. You packed your things and went home.

But John did not go home. Instead, he became the first pitcher to undergo a surgical procedure that seemed impossible at the time: a ligament transplant, taking a tendon from his forearm and grafting it to reconstruct the damaged ligament in his elbow. The surgeon was Frank Jobe, a visionary orthopedist working in Los Angeles. No one knew if it would work. No one knew if John would ever throw again, let alone pitch at the major league level.

He did. John returned to the mound and pitched for another fourteen seasons, winning 164 more games after the surgery. He became a four-time All-Star and a World Series champion. But his greatest legacy was not measured in wins or championships. It was measured in the thousands of athletes who came after him—pitchers, quarterbacks, tennis players, gymnasts—who faced career-ending injuries and found a path back to play because John had been willing to be the first.

The procedure that saved his career became known as Tommy John surgery, and it transformed orthopedic medicine. What was once a death sentence became routine. Young pitchers who tore their ulnar collateral ligaments no longer faced retirement; they faced rehabilitation and the realistic prospect of returning to professional baseball. The surgery became so common that some teams began to view it as an inevitable rite of passage for their young arms, a procedure many pitchers would undergo at some point in their careers.

John's willingness to undergo an experimental procedure—to be a guinea pig for medical science—opened a door that has never closed. Surgeons refined the technique. Athletes pushed harder in their recoveries. The procedure evolved, but the principle remained the same: an injury that had once ended careers could now be repaired. John died at 83, having lived a full life after an injury that should have ended his at 31. The surgery that bears his name has allowed countless others to do the same.

John returned to the mound and pitched for another fourteen seasons, winning 164 more games after the surgery
— Career record after surgery
Quer a matéria completa? Leia o original em NPR ↗
Fale Conosco FAQ